EDGAR Filing Documents for 0001615774-17-007272

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001615774-17-007272

Filing Date

2017-12-11

Accepted

2017-12-11 17:14:49

Documents

Period of Report

2017-09-30

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	s108360_10k.htm	10-K	1223182
2	EXHIBIT 10.7	s108360_ex10-7.htm	EX-10.7	85361
3	EXHIBIT 21.1	s108360_ex21-1.htm	EX-21.1	4222
4	EXHIBIT 23.1	s108360_ex23-1.htm	EX-23.1	7292
5	EXHIBIT 31.1	s108360_ex31-1.htm	EX-31.1	12333
6	EXHIBIT 31.2	s108360_ex31-2.htm	EX-31.2	11980
7	EXHIBIT 32.1	s108360_ex32-1.htm	EX-32.1	5380
8	EXHIBIT 99.1	s108360_ex99-1.htm	EX-99.1	35200
	Complete submission text file	0001615774-17-007272.txt		4256031

Data Files

Seq	Description	Document	Type	Size
9	XBRL INSTANCE FILE	avxl-20170930.xml	EX-101.INS	775977
10	XBRL SCHEMA FILE	avxl-20170930.xsd	EX-101.SCH	38725
11	XBRL CALCULATION FILE	avxl-20170930_cal.xml	EX-101.CAL	33742
12	XBRL DEFINITION FILE	avxl-20170930_def.xml	EX-101.DEF	115422
13	XBRL LABEL FILE	avxl-20170930_lab.xml	EX-101.LAB	305206
14	XBRL PRESENTATION FILE	avxl-20170930_pre.xml	EX-101.PRE	194301

Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163

Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939

ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)